Worldwide Blood Screening and Typing (ABO Grouping, Immunoassay Screen, NAT Screen) Markets 2015-2020

Feb 22, 2016, 13:10 ET from Research and Markets

DUBLIN, Feb. 22, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Blood Screening and Typing Markets" report to their offering.

A variety of infectious agents can be present in blood, including viruses, bacteria, protozoans, Chagas disease, Lyme Disease, and prions. Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease.

Blood Screening and Typing Markets examines the infectious disease blood typing and the infectious disease blood screening markets, including complete market analysis of the blood screening and typing markets:

  • Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Selected Blood Typing Innovations
  • Blood Typing by Country, 2015 (%)
  • Infectious Disease Blood Typing Market Share by Company
  • Immunoassay Testing Market by Country, 2015  (%)
  • Selected New Blood Screening Immunoassays
  • NAT Blood Screening Market by Country, 2015  (%)
  • Selected New Blood Screen NAT Tests and Systems
  • Infectious Disease Blood Screening Test Market Share by Company

The report provides a comprehensive overview of the blood screening and typing markets, discussing:

  • Risk of Contamination
  • Viral Inactivation by Procedure
  • Basic Blood Types
  • Blood Transfusion Compatibility
  • PCR-Based Screening Tests Licensed by CBER
  • Comparison of Direct and Indirect ELISA Tests
  • Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
  • Blood Component Usage
  • Pathogens Commonly Tested in Donated Blood Units
  • Selected Pathogen Screening Innovations

Blood Screening and Typing Markets profiles a selection of companies that specialize in blood banking and that contribute molecular test innovation to this segment. Companies discussed include Grifols and Roche Diagnostics.

Key Topics Covered:


  • Blood Screening
  • Blood Typing
  • The Market for Blood Testing and Typing


  • Reducing Blood Typing Errors
  • Improving Donor Screening
  • Improving Viral Screening
  • Increasing Repeat Donation Rates
  • Enhancing Viral Inactivation Processes
  • Increasing Voluntary Donation
  • Preventing Bacterial Infections
  • Biovigilance
  • Other Safety Precautions
  • Blood Typing
  • Methods of Blood Typing
  • Blood Testing
  • Nucleic Acid Amplification Testing (NAT)
  • CBER Licensed NAT Screening Tests
  • Polymerase Chain Reaction (PCR) Amplification
  • CBER Licensed PCR Screening Tests
  • Immunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Costs and Other Barriers
  • Blood Storage
  • Blood Transfusions
  • Blood Pathogen Screening


  • Blood Banking Gets a Shakeup
  • Blood Typing
  • Blood Grouping and Typing
  • Immunoassays
  • Nucleic Acid Testing (NAT)
  • Market Share in Blood Testing


  • Abbott Diagnostics
  • AXO Science
  • Beckman Coulter
  • bioMérieux Inc
  • Cerus Corporation
  • DiaSorin S.p.A
  • Grifols
  • Blood Transfusion Novartis Business
  • International Programs
  • Haemonetics Corporation
  • Hologic, Inc.
  • Product News
  • The Gen-Probe Business
  • Panther System
  • Blood Bank
  • Quest Contract
  • Immucor, Inc.
  • Immunetics Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Roche Diagnostics
  • Terumo BCT
  • Verax Biomedical Inc.

For more information visit

Media Contact:

Laura Wood , +353-1-481-1716,

Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716



SOURCE Research and Markets